一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集

Abstract

Full Text of PDF Full Text of PDF (558k)
Article in Japanese

Original Article

Clinical features and their correlations with the serum levels of VEGF-C, VEGF-D, and VEGF-R3 in patients with lymphangioleiomyomatosis

Hiroko Okabayashi  Aiko Masunaga  Hidenori Ichiyasu  Shinsuke Tsumura  Keisuke Kojima  Sho Saeki  Junji Hamamoto  Kazuhiko Fujii  Naoki Saita  Hirotsugu Kohrogi 

Department of Respiratory Medicine, Kumamoto University Hospital

ABSTRACT

Lymphangioleiomyomatosis (LAM) is characterized by a proliferation of LAM cells, a smooth-muscle-like cell type, in the lungs, lymph nodes, and other organs. Their proliferation induces LAM by producing vascular endothelial growth factors (VEGFs). These cells express VEGFs, and lymphatic endothelial cells in the lesions of LAM express VEGF-R3 and the receptors of VEGF-C and -D. Because the serum level of VEGF-D is elevated in patients with LAM, it may serve as a diagnostic marker of LAM. In the present study, we measured the serum levels of VEGF-C, VEGF-D, and VEGF-R3 in 6 patients with LAM and compared these levels with those in patients having chronic obstructive pulmonary disease and with healthy volunteers. The serum levels of VEGF-D were significantly higher in patients with LAM than in healthy volunteers, and they were negatively correlated with FEV1.0% and %DLCO, but they were not significant. The serum levels of VEGF-R3 were higher in patients with LAM than in the other groups, but the difference was insignificant. We suggest that serum VEGF-D is a useful marker for the diagnosis of LAM and the evaluation of its severity.

KEYWORDS

Lymphangioleiomyomatosis  Lymphangiogenesis  Vascular endothelial growth factor  Vascular endothelial growth factor receptor  Lung function 

Received 8 Jun 2011 / Accepted 17 Oct 2011

AJRS, 1(2): 89-94, 2012

Google Scholar